Neuberger Berman Group’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-470,900
| Closed | -$25.2M | – | 1748 |
|
|
2020
Q4 | $25.2M | Buy |
470,900
+92,800
| +25% | +$4.96M | 0.03% | 574 |
|
|
2020
Q3 | $15.6M | Buy |
378,100
+160,000
| +73% | +$6.6M | 0.02% | 636 |
|
|
2020
Q2 | $10.6M | Buy |
218,100
+165,000
| +311% | +$8M | 0.01% | 703 |
|
|
2020
Q1 | $2.24M | Buy |
53,100
+13,000
| +32% | +$549K | ﹤0.01% | 921 |
|
|
2019
Q4 | $1.72M | Buy |
40,100
+13,700
| +52% | +$586K | ﹤0.01% | 1058 |
|
|
2019
Q3 | $950K | Buy |
26,400
+2,800
| +12% | +$101K | ﹤0.01% | 1160 |
|
|
2019
Q2 | $631K | Buy |
23,600
+10,600
| +82% | +$283K | ﹤0.01% | 1244 |
|
|
2019
Q1 | $349K | Buy |
+13,000
| New | +$349K | ﹤0.01% | 1331 |
|
|
2017
Q3 | – | Sell |
-62,664
| Closed | -$1.75M | – | 1589 |
|
|
2017
Q2 | $1.75M | Buy |
62,664
+29,326
| +88% | +$818K | ﹤0.01% | 1021 |
|
|
2017
Q1 | $1.15M | Buy |
+33,338
| New | +$1.15M | ﹤0.01% | 1112 |
|
|
2015
Q2 | – | Sell |
-391,600
| Closed | -$12.8M | – | 1553 |
|
|
2015
Q1 | $12.8M | Buy |
391,600
+365,800
| +1,418% | +$11.9M | 0.01% | 790 |
|
|
2014
Q4 | $819K | Buy |
+25,800
| New | +$819K | ﹤0.01% | 1258 |
|
|
2014
Q3 | – | Sell |
-16,325
| Closed | -$369K | – | 1637 |
|
|
2014
Q2 | $369K | Sell |
16,325
-27,625
| -63% | -$624K | ﹤0.01% | 1444 |
|
|
2014
Q1 | $1.07M | Sell |
43,950
-7,985
| -15% | -$194K | ﹤0.01% | 1202 |
|
|
2013
Q4 | $1.3M | Buy |
+51,935
| New | +$1.3M | ﹤0.01% | 1152 |
|